Full course vaccines provide super immunity against COVID 19, confirms research |
Tafesse's research comes nearly two years into the pandemic, as health experts and international leaders struggle to respond to the virus's most recent version i.e. the quickly spreading omicron. Tafesse's study did not include the new variant, but he believes the same findings would apply to it as well. After the delta variant and poor vaccination rates dashed hopes of an end to the epidemic this summer, health experts and the general public have been concerned about new subsequent waves of coronavirus variants.
Read | Researcher says, COVID-19 Boosters can help in preventing the third wave
However preliminary research indicates that omicron can
easily avoid vaccinated people's immune systems and can still spread faster than
the delta form. According to one of Tafesse's project partners, the OHSU
research suggests a possible "end game" for the pandemic." It
hints to where we're likely to arrive," said Dr. Marcel Curlin, associate
professor of medicine and research co-author. "Once you've been vaccinated
and then exposed to the virus, you should be reasonably well protected from
future variants."Even when immunity is diminishing, the immune system's
antibody manufacturers, or "memory B cells," remain ready to produce
the necessary antibodies within days after a fresh virus encounter, according
to Curlin. Still, it's unclear what specific, practical
consequences the study gives, whether for the 2.7 million Oregonians who have
been properly vaccinated or the 48,000 who were infected anyway.
Tafesse (Assistant professor of molecular microbiology
and immunology at OHSU), analyzed immune system responses in blood samples to get his research done. He collected samples from 52 completely vaccinated OHSU employees, 26 of whom had
breakthrough infections. Tafesse's lab exposed blood
samples from participants to live samples of five coronavirus types, including
delta and assessed the volume and effectiveness of the antibodies produced in
response. They discovered a consistent pattern: antibodies in the blood of
people who had a breakthrough infection were up to 1,000% more potent than
antibodies produced by people who had simply been vaccinated. Antibodies are an
important line of defense for the immune system against any infection. The first
viral infection, or vaccination dosage, trains the immune system on how to
recognize the virus. When another virus is exposed or infected, antibodies
designed specifically for that virus seek out, bind to, and neutralize the
virus. "Our findings imply that people who have been vaccinated and
subsequently are exposed to a breakthrough infection have exceptional
immunity," Tafesse said.
Not only did those with illnesses have more antibodies in
their blood, but those antibodies were also more flexible. They correctly
identified distinct variants as variants of the same, underlying pathogen and
behaved accordingly. Tafesse believes antibodies would detect omicron and
elicit a similarly powerful response because the reaction and pattern were so
strong. Tafesse is now attempting to answer if booster doses provide the same
level of protection as breakthrough infections. He stated that he wants to have
the results of his continuing research into that question available by
mid-January.
Read | Plant-based chewing gum will fight off COVID 19 transmission? Here what scientist says
Pfizer-BioNTech reported last week that when exposed to the
omicron variant, blood from persons who received three doses of their vaccine
produced 25 times more antibodies than blood from people who received two
doses. Tafesse called it a "very, very significant" question because
he wants to advise the public to get booster shots. Even though
he anticipates the two to be equivalent, breakthrough infections may provide
more protection. Vaccines only target certain parts of the virus, which means
that if those parts mutate, a vaccinated immune system may not detect the
altered strain as the coronavirus.
Meanwhile, a breakthrough infection can train the immune
system to recognize the coronavirus based on considerably more characteristics.
"There is some benefit to being exposed to the entire virus," he
says, though he expects it to be "small." One clear takeaway from
Tafesse's research is that patients must have their initial vaccination course
to develop a foundation of immunity. "You must get the vaccine to
have this immunological response," Tafesse explained.
According to Tafesse's colleague, Curlin, antibodies in persons who had a breakthrough case are far more effective than antibodies in those who weren't fully vaccinated when they were sick. And the study is by no means an endorsement for vaccinated people to obtain COVID-19. While most breakthrough infections are modest, they can nevertheless cause significant disease and death. Approximately 2,100 Oregonians have been hospitalized with breakthrough COVID-19 infections, with 580 deaths. The average age of those who died was 81. "We're not encouraging people to get sick," he stated.
If you need more information about the helping topics, please write to us. we will revert you soon